Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

Autor: Liam Mullen, Mohammed N. Meah, Ahmed Elamin, Suneil Aggarwal, Adeel Shahzad, Matthew Shaw, Jaroslav Hasara, Muhammad Rashid, Michael Fisher, Turab Ali, Billal Patel, Wern Y. Ding, Ruth Grainger, Thomas Heseltine, Bilal H. Kirmani, Mohammed Obeidat, Yande Kasolo, Jecko Thatchil, Aleem Khand

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 8 (2021)

Background Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. Methods and Results Major bleeding, subsequent myocardial infarction (MI), and all‐ca

Externí odkaz: https://doaj.org/article/5a1bdb165625475aa1ad1ae17d6bf17b

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

Autor: Jaroslav Hasara, Liam Mullen, Yande Kasolo, Thomas Heseltine, Bilal H. Kirmani, Muhammad Rashid, Ruth Grainger, Ahmed Elamin, Billal Patel, Adeel Shahzad, Matthew Shaw, Michael Fisher, Jecko Thatchil, Mohammed Obeidat, Aleem Khand, Turab Ali, Mohammed Meah, Wern Yew Ding, Suneil Aggarwal

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Mullen, L, Meah, M N, Elamin, A, Aggarwal, S, Shahzad, A, Shaw, M, Hasara, J, Rashid, M, Fisher, M, Ali, T, Patel, B, Ding, W Y, Grainger, R, Heseltine, T, Kirmani, B H, Obeidat, M, Kasolo, Y, Thatchil, J & Khand, A 2021, ' Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event : A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice ', Journal of the American Heart Association, vol. 10, no. 8, e019467 . https://doi.org/10.1161/JAHA.120.019467
JOURNAL OF THE AMERICAN HEART ASSOCIATION

Background Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. Methods and Results Major bleeding, subsequent myocardial infarction (MI), and all‐ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98efda80b404775d94438f71801e390
http://europepmc.org/articles/PMC8174168

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.

Autor: Mullen, Liam, Meah, Mohammed N., Elamin, Ahmed, Aggarwal, Suneil, Shahzad, Adeel, Shaw, Matthew, Hasara, Jaroslav, Rashid, Muhammad, Fisher, Michael, Ali, Turab, Patel, Billal, Ding, Wern Y., Grainger, Ruth, Heseltine, Thomas, Kirmani, Bilal H., Obeidat, Mohammed, Kasolo, Yande, Thatchil, Jecko, Khand, Aleem

Publikováno v: Journal of the American Heart Association; 4/20/2021, Vol. 10 Issue 8, Preceding p1-12, 25p